Physical AI at the inflection: evidence to scale

Before leadership funds the next phase, three questions a lab result cannot answer have to be resolved: liability, the sim-to-real gap and operational continuity.

By Harinderpal Hanspal on May 2026. Updated October 2026

The technology has cleared the lab and the early pilots have run. Now leadership is asked to fund the next phase, and the bar is commercial. Physical AI adds three questions a lab result cannot answer, and any one of them can stall a deal the technology would have won.

Three questions a lab result cannot answer can each stall a physical AI deal A lab result and early pilots feed three separate questions, liability, the sim-to-real gap and operational continuity, and all three must clear before the next phase is funded. A red note says any one can stall the deal. Lab result and early pilots Technology cleared Liability Who answers if it harms a worker? The sim-to-real gap Is adapting to each site manageable? Operational continuity Does it fit a schedule that never stops? Fund the next phase The bar is commercial Any one of the three can stall the deal
Three questions a lab result cannot answer can each stall a physical AI deal

Liability. Who answers if the system harms a worker, damages equipment or interrupts operations? A structure the buyer's legal and environment, health and safety (EHS) teams have accepted is Verified. "We are working through it" is an Assumption.

The sim-to-real gap. Is adapting the system to each site commercially manageable, or does it need custom engineering per site that changes the unit economics?

Operational continuity. Do maintenance, recalibration and failure recovery fit a production schedule that does not stop? The operations leader answers that one, not the engineering team.

Objectivity is scarcest at this point. The team that built the program has the most conviction and the least reason to press on these questions, while investors and partners read outside figures. MIT Project NANDA's preliminary 2025 report on generative AI found that about 5% of integrated AI pilots were extracting millions in value. It does not size the odds for physical AI, but it shows the scrutiny a scale decision meets. A scale decision should rest on scored, independent evidence from the buyers and operations leaders at representative sites, and end in a named verdict.

Go deeper: Validating physical AI before the capital is irreversible is the full argument, Before an AI agent writes to equipment: what the joint CISA guidance asks for, at the inflection covers what a scale-up Sprint tests, and how we validate physical AI grades each of the three questions.